Advances in the Role of Endothelial Cells in Cerebral Small Vessel Disease

Overview

Journal Front Neurol

Specialty Neurology

Date 2022 Apr 28

PMID 35481273

Authors

Tao Bai

Shijia Yu

Juan Feng

Affiliations

Soon will be listed here.

Abstract

Cerebral small vessel disease (CSVD) poses a serious socio-economic burden due to its high prevalence and severe impact on the quality of life of elderly patients. Pathological changes in CSVD mainly influence small cerebral arteries, microarteries, capillaries, and small veins, which are usually caused by multiple vascular risk factors. CSVD is often identified on brain magnetic resonance imaging (MRI) by recent small subcortical infarcts, white matter hyperintensities, lacune, cerebral microbleeds (CMBs), enlarged perivascular spaces (ePVSs), and brain atrophy. Endothelial cell (EC) dysfunction is earlier than clinical symptoms. Immune activation, inflammation, and oxidative stress may be potential mechanisms of EC injury. ECs of the blood-brain-barrier (BBB) are the most important part of the neurovascular unit (NVU) that ensures constant blood flow to the brain. Impaired cerebral vascular autoregulation and disrupted BBB cause cumulative brain damage. This review will focus on the role of EC injury in CSVD. Furthermore, several specific biomarkers will be discussed, which may be useful for us to assess the endothelial dysfunction and explore new therapeutic directions.

Citing Articles

Predicting Cerebral Small Vessel Disease Burden Based on Thromboelastography in Patients with Acute Ischemic Stroke: A Pilot Study.

Xia M, Wu D, Yu N, Huang G Med Sci Monit. 2025; 31:e946303.

PMID: 39972986 PMC: 11853390. DOI: 10.12659/MSM.946303.

Association between impaired brachial flow-mediated dilation and early neurological deterioration in acute ischemic stroke: a retrospective analysis.

Ha S, Yoon B, Koo B, Shin D, Lee Y, Kim B BMC Neurol. 2025; 25(1):47.

PMID: 39905287 PMC: 11792372. DOI: 10.1186/s12883-025-04048-0.

The Cardiac Output-Cerebral Blood Flow Relationship Is Abnormal in Most Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with a Normal Heart Rate and Blood Pressure Response During a Tilt Test.

van Campen C, Verheugt F, Rowe P, Visser F Healthcare (Basel). 2025; 12(24.

PMID: 39765993 PMC: 11675211. DOI: 10.3390/healthcare12242566.

Endothelial cells as key players in cerebral small vessel disease.

Kremer R, Williams A, Wardlaw J Nat Rev Neurosci. 2025; 26(3):179-188.

PMID: 39743557 DOI: 10.1038/s41583-024-00892-0.

Associations of Circulating Platelet Endothelial Cell Adhesion Molecule-1 Levels With Progression of Cerebral Small-Vessel Disease, Cognitive Decline, and Incident Dementia.

Sim M, Tan E, Chan S, Cai Y, Chai Y, Chong J J Am Heart Assoc. 2024; 13(22):e035133.

PMID: 39526361 PMC: 11681413. DOI: 10.1161/JAHA.124.035133.

References

Cirillo P, Pacileo M, De Rosa S, Calabro P, Gargiulo A, Angri V . Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells. J Thromb Haemost. 2006; 4(10):2248-55. DOI: 10.1111/j.1538-7836.2006.02125.x. View

Gons R, de Laat K, van Norden A, van Oudheusden L, van Uden I, Norris D . Hypertension and cerebral diffusion tensor imaging in small vessel disease. Stroke. 2010; 41(12):2801-6. DOI: 10.1161/STROKEAHA.110.597237. View

Young V, Halliday G, Kril J . Neuropathologic correlates of white matter hyperintensities. Neurology. 2008; 71(11):804-11. DOI: 10.1212/01.wnl.0000319691.50117.54. View

Lu Y, Hao R, Wei Y, Yu G . The protective effect of harpagoside on angiotensin II (Ang II)-induced blood-brain barrier leakage in vitro. Phytother Res. 2021; 35(11):6241-6254. DOI: 10.1002/ptr.7269. View

Keramidas M, Kounalakis S, Eiken O, Mekjavic I . Carbon monoxide exposure during exercise performance: muscle and cerebral oxygenation. Acta Physiol (Oxf). 2011; 204(4):544-54. DOI: 10.1111/j.1748-1716.2011.02363.x. View

Yang S, Cai J, Lu R, Wu J, Zhang M, Zhou X . Association Between Serum Cystatin C Level and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease in Patients With Acute Lacunar Stroke. J Stroke Cerebrovasc Dis. 2016; 26(1):186-191. DOI: 10.1016/j.jstrokecerebrovasdis.2016.09.007. View

Kruger-Genge A, Blocki A, Franke R, Jung F . Vascular Endothelial Cell Biology: An Update. Int J Mol Sci. 2019; 20(18). PMC: 6769656. DOI: 10.3390/ijms20184411. View

Cao Y, Su N, Zhang D, Zhou L, Yao M, Zhang S . Correlation between total homocysteine and cerebral small vessel disease: A Mendelian randomization study. Eur J Neurol. 2020; 28(6):1931-1938. DOI: 10.1111/ene.14708. View

Arntz R, van den Broek S, van Uden I, Ghafoorian M, Platel B, Rutten-Jacobs L . Accelerated development of cerebral small vessel disease in young stroke patients. Neurology. 2016; 87(12):1212-9. PMC: 5035980. DOI: 10.1212/WNL.0000000000003123. View

10.

Wardlaw J, Smith E, Biessels G, Cordonnier C, Fazekas F, Frayne R . Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013; 12(8):822-38. PMC: 3714437. DOI: 10.1016/S1474-4422(13)70124-8. View

11.

Ighodaro E, Abner E, Fardo D, Lin A, Katsumata Y, Schmitt F . Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab. 2016; 37(1):201-216. PMC: 5363738. DOI: 10.1177/0271678X15621574. View

12.

Brodsky S, Zhang F, Nasjletti A, Goligorsky M . Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol. 2004; 286(5):H1910-5. DOI: 10.1152/ajpheart.01172.2003. View

13.

Nafisa A, Gray S, Cao Y, Wang T, Xu S, Wattoo F . Endothelial function and dysfunction: Impact of metformin. Pharmacol Ther. 2018; 192:150-162. DOI: 10.1016/j.pharmthera.2018.07.007. View

14.

Cuadrado-Godia E, Dwivedi P, Sharma S, Ois Santiago A, Roquer Gonzalez J, Balcells M . Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies. J Stroke. 2018; 20(3):302-320. PMC: 6186915. DOI: 10.5853/jos.2017.02922. View

15.

Hlubocka Z, Umnerova V, Heller S, Peleska J, JINDRA A, Jachymova M . Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. J Hum Hypertens. 2002; 16(8):557-62. DOI: 10.1038/sj.jhh.1001403. View

16.

McCarthy E, Wilkinson F, Parker B, Alexander M . Endothelial microparticles: Pathogenic or passive players in endothelial dysfunction in autoimmune rheumatic diseases?. Vascul Pharmacol. 2016; 86:71-76. DOI: 10.1016/j.vph.2016.05.016. View

17.

Hassan A, Hunt B, OSullivan M, Bell R, DSouza R, Jeffery S . Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain. 2003; 127(Pt 1):212-9. DOI: 10.1093/brain/awh023. View

18.

Notsu Y, Nabika T, Bokura H, Suyama Y, Kobayashi S, Yamaguchi S . Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage. Am J Hypertens. 2008; 22(3):257-62. DOI: 10.1038/ajh.2008.346. View

19.

Song R, Chou Y, Kong J, Li J, Pan B, Cui M . Association of endothelial microparticle with NO, eNOS, ET-1, and fractional flow reserve in patients with coronary intermediate lesions. Biomarkers. 2015; 20(6-7):429-35. DOI: 10.3109/1354750X.2015.1094140. View

20.

Pavlovic A, Pekmezovic T, Zidverc Trajkovic J, Tomic G, Cvitan E, Sternic N . Increased risk of cognitive impairment and more severe brain lesions in hypertensive compared to non-hypertensive patients with cerebral small vessel disease. J Clin Hypertens (Greenwich). 2018; 20(9):1260-1265. PMC: 8031348. DOI: 10.1111/jch.13357. View